hotspot -WSS

hotspot

author：Wikipedia 2025-09-29 22:49:37 - browse：4472

Obesity conference attendees with a pink and blue Wegovy sign hanging from the ceiling above. -- obesity coverage from STAT — Wegovy, the obesity drug, was inescapable at the ObesityWeek conference in Dallas. Elaine Chen

DALLAS — Here at ObesityWeek, one of the largest conferences on obesity, Novo Nordisk and Eli Lilly are displaying more than a dozen studies that together carry the message: Our blockbuster weight loss treatments will be worth it for society.

But experts point out that much of this company-funded research does not include the cost of the drugs themselves, which sell at more than $10,000 per year in the U.S. and are meant to be taken indefinitely.

The two major pharmaceutical companies have seen interest skyrocket for their GLP-1-based drugs like Ozempic, Wegovy, and Mounjaro, a new generation of medications that can cut substantial amounts of weight. But insurance plans have been slow to grant wide access to obesity treatments, concerned that the vast amount of people eligible to take them, along with their high price, could lead to significant financial strain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Victims of gun violence feel impacts long after bullet wound

knowledge

WSS

Brain worms: The science behind RFK Jr.'s parasitic infection

Steward Health Care files for bankruptcy

Removing probiotics from the NICU could threaten preemies' health

Steward Health Care files for bankruptcy

First recipient of genetically engineered pig kidney has died

Ambulance rides for just $100? Advisers want major billing fixes

explore

hotspot

hotspot

After affirmative action ruling, medical educators look to 'holistic review'

Sanofi strikes deal with Novavax, boosting the vaccine maker

Wildfire smoke exposes gaps in outdoor worker protections

Biotech incubator Curie.Bio graduates its first startup

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Will General Catalyst be the first of many hospital takeovers?

DIEP, the 'gold standard' of breast reconstruction, is under threat

Brain worms: The science behind RFK Jr.'s parasitic infection

The high cost of giving birth even with insurance

Free speech concerns arise in wake of journal editor Eisen's firing

focus

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

FDA approves Recor Medical high blood pressure device

Apple Watch's A

Biotech incubator Curie.Bio graduates its first startup

Bird flu outbreak in cows is latest avian flu curveball

entertainment

knowledge

hotspot

leisure time